publication, a preprint has been posted on the bioRxiv web server showing that a split Cas9-gRNA gene drive system efficiently biases inheritance in yeast (6). The split system was used to avoid accidental escape of the gene drives. The use of a similar strategy in future MCR organisms would reduce, but not eliminate, risks associated with accidental release. We therefore concur with others (7, 8) that a dialogue on this topic should become an immediate high-priority issue. Perhaps, by analogy to the famous Asilomar meeting of 1975 that assessed the risks of recombinant DNA technology, a similar conference could be convened to consider biosafety measures and institutional policies appropriate for limiting the risk of engaging in MCR research while affording workable opportunities for positive applications of this concept.
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In cells, biosynthetic machinery coordinates protein synthesis and folding to optimize efficiency and minimize off-pathway outcomes. However, it has been difficult to delineate experimentally the mechanisms responsible. Using fluorescence resonance energy transfer, we studied cotranslational folding of the first nucleotide-binding domain from the cystic fibrosis transmembrane conductance regulator. During synthesis, folding occurred discretely via sequential compaction of N-terminal, a-helical, and a/b-core subdomains. Moreover, the timing of these events was critical; premature a-subdomain folding prevented subsequent core formation. This process was facilitated by modulating intrinsic folding propensity in three distinct ways: delaying a-subdomain compaction, facilitating b-strand intercalation, and optimizing translation kinetics via codon usage. Thus, de novo folding is translationally tuned by an integrated cellular response that shapes the cotranslational folding landscape at critical stages of synthesis.
M
ost proteins must acquire a defined three-dimensional structure in order to function. Folding pathways that generate these structures have primarily been characterized by using model substrates that fold rapidly, spontaneously, and reversibly in vitro (1, 2) . In cells, however, protein folding is kinetically coupled to synthesis as the nascent polypeptide emerges from the ribosome. Whereas certain small proteins may remain unstructured during synthesis (3), many complex proteins exhibit length-dependent folding intermediates whose structural properties (4) and/or folding efficiencies (5) deviate from those observed in vitro. In such cases, the folding energy landscape, as well as folding outcome, can be influenced by ribosome effects (4, 6, 7), polypeptide elongation rate (8-10), molecular crowding (11, 12) , and cotranslational interactions with cellular chaperones (13, 14) . Indeed, cotranslational constraints can bias kinetically competing folding events to generate alternate stable structures with different functional properties (8, 15, 16) . Despite improved computational methods, few principles have been established experimentally to explain how biosynthetic parameters influence specific folding events and outcome (3, 4, (17) (18) (19) .
To address this issue, we used fluorescence resonance energy transfer (FRET) to examine structural transitions of ribosome-bound folding intermediates generated through in vitro translation of truncated RNA transcripts. This approach derives from the principle that during folding, certain residues distant in primary structure are brought into close proximity, increasing the FRET efficiency between donor and acceptor fluorophores that are cotranslationally incorporated into the nascent polypeptide (Fig. 1A) (18, 19) . Here, the donor fluorophore, cyan fluorescent protein (CFP), was fused to the N terminus of the first nucleotide-binding domain (NBD1) from the cystic fibrosis transmembrane conductance regulator (CFTR), and a small acceptor dye was incorporated at surface-exposed residues (UAG codons) by using a synthetic suppressor tRNA (figs. S1 and S2). FRET measurements obtained at sequential nascent chain lengths thus provide conformational snapshots into the equilibrium ensemble of stably arrested ribosome-bound nascent chains in the context of their native biosynthetic machinery (Fig. 1A) (3, (17) (18) (19) (20) .
Using this system, we defined the cotranslational folding pathway of CFTR NBD1, whose defective folding causes cystic fibrosis (21) (22) (23) (24) . NBD1 contains three subdomains (N-terminal, a-helical, and parallel-F1-type-b-sheet core) and exhibits a complex vectoral topography that limits CFTR maturation (22, 25) and prevents reversible folding in vitro. To examine its cotranslational folding pathway, FRET acceptor sites were chosen within 4 to 9 Å of the CFP fusion (Thr 389 ) (26) to report on the positioning of strands S3, S6, S7, and S8 in the b-sheet core (Fig. 1, B and C) . Analysis of sequentially stalled polypeptides yielded a characteristic length-dependent rise and plateau in FRET for each acceptor site (Fig.  1D ). This rise in FRET reports on acquisition of a native-like fold (19) and reflects the earliest biosynthetic stage at which the acceptor dye and its corresponding b-strand are optimally positioned within NBD1. Results show that S3, S6, S7, and S8 could therefore reach a native-like structure when the ribosome has synthesized residues 550, 624, 654, and 674, respectively (Fig. 1D) , although actual folding intermediates will depend on relative folding kinetics and translation elongation rate.
Despite their proximity, S6 exhibited a more gradual rise in FRET and was optimally positioned at a later stage of synthesis than was S3 (Fig. 1D ). Because the ribosome exit tunnel sequesters approximately 40 residues, optimal S6 positioning 1D ) polypeptides plotted against number of cytosolic residues (#) C-terminal to the acceptor site (n ≥ 3 T SEM or average of n = 2 replicates) located at residues 450, 487, 567, in (B), (D), and (F), respectively. (G) Illustration depicting (i) role of ribosome in delaying S6 and a-subdomain folding to facilitate S7 and S8 insertion and (ii) resultant NBD1 misfolding due to premature S6/a-subdomain folding in the absence of ribosome.
was therefore delayed until the entire a-subdomain and S7 emerged into the cytosol (Fig. 1D) . To understand this delay, we compared the conformation of S3 and S6 in ribosome-bound versus ribosome-released polypeptides, where each construct contained equivalent cytosolically exposed residues ( Fig. 2) (19, 27) . Under these conditions, ribosome attachment had no detectable impact on N-terminal subdomain folding (Fig. 2, A and  B, and fig. S3A ). In contrast, S6 exhibited a higher FRET efficiency and achieved a native-like conformation at shorter chain lengths (by nearly 50 residues) in the ribosome-free state (Fig. 2, C and  D, and fig. S3B ). Ribosome attachment therefore delayed S6 positioning during a-subdomain synthesis.
In adenosine 5´-triphosphate-binding cassette transporters, S7 and S8 are synthesized after the a-subdomain and must intercalate between S3 and S6 to form the four-strand hydrophobic b-sheet core (Fig. 1, B and C ). Yet, S6, S7, and S8 are all positioned into the native NBD fold at a similar stage of synthesis (Fig. 1D) . Because optimal S7 positioning requires S8 and is a prerequisite for CFTR folding ( fig. S4) , we tested whether ribosome-mediated delay of S6 positioning might facilitate b-sheet core formation. Indeed, ribosome release before core folding prevented S7 insertion, as evidenced by a reduction in FRET efficiency (Fig. 2, E and F, and fig. S3, C and D) . The ribosome therefore exhibits two opposite but interrelated effects on nascent chain conformation that directly influence folding outcome: delaying spontaneous folding at one stage of synthesis (S6 positioning), while enabling folding at another (S7/S8 intercalation). Because premature polypeptide release uncouples these events, the ribosome appears to facilitate NBD1 folding, potentially in concert with associated chaperones, by maintaining a relatively open a-subdomain conformation to ensure orderly and sequential insertion of S6, S7, and S8 during a critical translational window (Fig. 2G) .
These results predict that b-sheet core formation depends on the timing and/or kinetics of a-subdomain folding. Because the predicted translation elongation rate (10) slows dramatically during a-subdomain synthesis (Fig. 3A and S1), we introduced synonymous codon substitutions predicted to either maximize or minimize the translation rate within this region (Fig. 3A  and fig. S5 ). Metabolic pulse labeling verified that Fast (525-593) synonymous codons did indeed increase the rate of NBD1 synthesis in cells (Fig. 3B  and fig. S6 ). Remarkably, despite generating identical amino acid sequences ( fig. S7 and table S2), Fast (525-593) codon substitutions resulted in aggregation of full-length CFTR (Band B) (Fig.  3C ) as well as isolated NBD1 ( fig. S8 ) 1 to 4 hours after synthesis, suggesting either delayed conversion into the insoluble fraction or less efficient degradation (Fig. 3, D and E) . In contrast, Slow (525-593) codon substitutions had no detectable effect on either NBD1 or full-length wildtype (WT) or DF508 CFTR (Fig. 3, B to D, and figs. S8 and S9). Similarly, Fast substitutions within codons 501 to 540 had no effect on CFTR aggregation ( fig. S10) .
Thus, the translation elongation rate appears to be tailored to folding needs of specific peptide regions and, in this case, kinetically couples a-subdomain and b-sheet core folding as H3 and H4 emerge from the ribosome (Fig. 3A) . This region is home to numerous suppressor mutations that improve NBD1 stability, CFTR folding efficiency, and DF508 CFTR processing (24, 28) . One such variant, D529F, improves NBD1 and full-length CFTR folding without affecting NBD1 thermal stability (25) , suggesting that it may act along the folding pathway. ). Phe substitution at this site might therefore affect timing of local a-subdomain collapse. Consistent with this hypothesis, D529F resulted in S7 positioning at an earlier stage of synthesis without affecting S6 (Fig. 4B and fig. S11A ). D529F also eliminated ribosome dependence for b-sheet core folding (Fig. 4C ) and suppressed aggregation of full-length CFTR caused by Fast (553-593) codon substitutions (Fig. 4D) , thus restoring kinetic coupling between a-helical subdomain and b-sheet core.
This study delineates cotranslational folding of a topologically complex protein as a series of dynamically modulated folding events that can be viewed as a function of chain length (Fig. 4E) . As the nascent polypeptide emerges from the ribosome, formation of low FRET-associated open conformers is interrupted by discrete intervals of peptide compaction. Although each of these folding events could be theoretically analogous to in vitro folding of an equivalent peptide domain (3), this does not appear to be the case. Rather, folding occurs in sequential, coupled steps, the timing of which is both positively and negatively influenced by biosynthetic machinery. Rapid cotranslational folding of the N-terminal subdomain likely provides a template for subsequent interfacial interactions that assist domain assembly (29) . In contrast, optimal folding of the noncontiguously synthesized b-strands is achieved by actively delaying placement of a presynthesized N-terminal strand (S6) until C-terminal strands (S7 and S8) are available. This process is coordinated by maintaining the nascent polypeptide in a folding-competent conformation (4, 27) both by direct ribosome effects (4, 7) and the translation rate as dictated by codon usage (11, 12) . Cotranslationally recruited chaperones (30) , not examined here, may also contribute to the delay in S6 placement and a-subdomain collapse (13) . We refer to this overall process as "translational tuning," in which multiple mechanisms are simultaneously integrated during synthesis to modulate intrinsic folding properties of the nascent chain. Translational tuning also integrates conserved codon usage with biophysical properties imposed by amino acid sequence, both of which are tailored to optimize outcome based on specific folding requirements (31, 32) . Severe influenza disease strikes otherwise healthy children and remains unexplained. We report compound heterozygous null mutations in IRF7, which encodes the transcription factor interferon regulatory factor 7, in an otherwise healthy child who suffered lifethreatening influenza during primary infection. In response to influenza virus, the patient's leukocytes and plasmacytoid dendritic cells produced very little type I and III interferons (IFNs). Moreover, the patient's dermal fibroblasts and induced pluripotent stem cell (iPSC)-derived pulmonary epithelial cells produced reduced amounts of type I IFN and displayed increased influenza virus replication. These findings suggest that IRF7-dependent amplification of type I and III IFNs is required for protection against primary infection by influenza virus in humans. They also show that severe influenza may result from singlegene inborn errors of immunity.
B oth seasonal and pandemic influenza viruses typically cause self-limiting respiratory disease but occasionally cause life-threatening acute respiratory distress syndrome (ARDS). The frequency of severe disease depends on the viral strain (1). Known host risk factors to severe influenza consist of a few acquired comorbidities, such as chronic pulmonary disease (2, 3). The pathogenesis of most cases of lifethreatening influenza remains unexplained, especially among children (4) . The lack of severe influenza in patients with known primary immunodeficiencies, including inborn errors of T and/or B cell immunity that predispose to a variety of related infections such as severe parainfluenza (5), is also unexplained (6). Only haploinsufficiency for GATA2, resulting in abnormal hematopoietic cell development, was reported in a few patients with severe influenza and other infections (7) . Monogenic inborn errors of immunity may underlie life-threatening, isolated diseases in otherwise healthy children during primary infection by a few other viruses (8) . We therefore hypothesized that severe influenza striking otherwise healthy children may also result from single-gene inborn errors of immunity.
We performed whole-exome sequencing (WES) in a 7-year-old girl ("P"), one of 22 individuals sequenced (including only three children <5 years old) proven to have developed influenza in the course of primary infection (table S1) (table S2) . She was born to nonconsanguineous parents of French descent (Fig. 1A and fig. S2A ). WES analysis of the trio revealed, and Sanger sequencing confirmed, two compound heterozygous IRF7 mutationsp.Phe410Val (F410V) and p.Gln421X (Q421X)-with 448 24 APRIL 2015 • VOL 348 ISSUE 6233 sciencemag.org SCIENCE
